New York, April 12 (IANS) US researchers have found a new method that may help in monitoring cancer from blood tests more easily and accurately.
The study, led by researchers from Weill Cornell Medicine and the New York Genome Center, in the US, showed that the method may be useful for monitoring disease status in patients following treatment.
The method, based on whole-genome sequencing of DNA, also represents an important step toward the goal of routine blood test-based screening for early cancer detection.
“We’re now entering an era of low-cost DNA sequencing, and in this study, we took advantage of that to apply whole-genome sequencing techniques that in the past would have been considered wildly impractical,” said Dr. Dan Landau, Professor of Medicine, at Weill Cornell Medicine.
In the study, published in the journal Nature Methods, the team focussed on an error-correcting method in a low-cost commercial sequencing platform.
The error-correction method makes use of the redundant information in natural two-stranded DNA.
The researchers found it enabled a very high “depth” of coverage — a measure of the sequencing data quality — allowing the team to detect extremely low concentrations of circulating tumour DNA. It also greatly improved the accuracy of the technique.
Blood-test-based “liquid biopsy” technology for early cancer detection and monitoring of cancer burden in patients could revolutionise cancer care, said the researchers.
The team demonstrated the potential of the high-sensitivity, low-error approach by using it to detect and assess very low cancer levels in patients with bladder cancer and melanoma from blood samples alone.
“We were able, for example, to see increases in circulating tumour DNA levels after treatment in patients with cancers that progressed or recurred and declines in those levels in patients whose cancers had full or partial responses,” said Dr. Alexandre Cheng, a postdoctoral researcher.
–IANS
rvt/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
